[Fosfomycin. II. Antimicrobial activity in vivo].
作者信息
Carlone N A, Cuffini A M, Savoia D
出版信息
G Batteriol Virol Immunol. 1977 Jul-Dec;70(7-12):215-25.
PMID:615746
Abstract
摘要
相似文献
1
[Fosfomycin. II. Antimicrobial activity in vivo].
G Batteriol Virol Immunol. 1977 Jul-Dec;70(7-12):215-25.
2
[Clinical experiments in the use of fosfomycin in oral microbial infections].
Dent Cadmos. 1983 Mar;51(3):57-64.
3
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections.磷霉素治疗全身感染患者的药代动力学和药效学特征的临床意义。
Int J Antimicrob Agents. 2009 Dec;34(6):506-15. doi: 10.1016/j.ijantimicag.2009.08.013. Epub 2009 Oct 13.
4
Efficacy of metronidazole and fosfomycin alone and in combination in the treatment of experimentally induced intra-abdominal infections.
Scand J Gastroenterol Suppl. 1984;90:15-9.
5
[Fosfomycin in the treatment of some infectious diseases].
Clin Ter. 1979 Jan 15;88(1):61-6.
6
[Phosphomycin for the prevention of bacterial infections in high risk patients].
Clin Ter. 1981 Nov 15;99(3):295-304.
7
[Study and use of fosfomycin in the clinical field].
G Ital Chemioter. 1978 Jan-Jun;25(1):1-4.
8
[Fosfomycin in urogenital infections. Experimental assumptions and clinical results].
Minerva Med. 1978 Dec 1;69(59):4087-91.
9
Fosfomycin. Controlled clinical studies.
G Ital Chemioter. 1977 Jul-Dec;23(2):127-32.
10
Experimental endocarditis and fosfomycin.
Drugs Exp Clin Res. 1985;11(1):55-62.
Zotero 插件